• Home
  • /
  • Advanced Workshop on CAR-T Therapy- Oncology and Beyond
Find a workshopPay feeRequest a callbackVerify a certificate


Workshop Registration End Date :2024-12-18

Virtual Workshop

Advanced Workshop on CAR-T Therapy: Oncology and Beyond

“Advancing CAR-T Therapy: From Oncology to Novel Applications”

MODE
Virtual (Google Meet)
TYPE
Mentor Based
LEVEL
Advanced
DURATION
3 Days (1.5 hours per day)
Start Date
18 – Dec – 24
Time
3:00 PM IST

About

CAR-T therapy has revolutionized the field of oncology, offering personalized and highly effective treatments for certain cancers. This 3-day workshop dives deep into the biological principles behind CAR-T therapy, from T-cell engineering to antigen targeting, along with real-world applications and case studies in oncology. Participants will explore the full therapeutic landscape, including FDA-approved therapies and emerging treatments.
Beyond oncology, CAR-T therapy is now being explored for autoimmune diseases, infectious diseases, and other non-cancerous conditions. The workshop will discuss the future directions of CAR-T research and clinical trials, addressing the current hurdles in scaling these therapies. Participants will also engage in practical sessions, including CAR-T cell manufacturing, regulatory frameworks, and understanding the ethical considerations surrounding gene editing and cellular therapies.

Edit

Aim

This advanced workshop on “CAR-T Therapy: Oncology and Beyond” aims to provide a comprehensive understanding of Chimeric Antigen Receptor (CAR) T-cell therapy, its mechanisms, clinical applications, and future potential beyond oncology. Participants will gain insights into the latest developments, challenges, and innovations in CAR-T therapy for both cancer treatment and other emerging applications.

Edit

Workshop Objectives

  • Understand the fundamentals of CAR-T cell biology and immunotherapy mechanisms.
  • Explore CAR-T therapy applications in oncology and beyond.
  • Learn about the latest innovations, clinical trials, and emerging applications.
  • Gain practical knowledge of CAR-T cell manufacturing and regulatory requirements.
  • Discuss ethical, safety, and scalability challenges in CAR-T therapy.

Edit

Workshop Structure

Day 1: Introduction to CAR-T Therapy

Workshop Overview 

  • Introduction to the workshop structure and objectives
  • Importance of CAR-T therapy in modern oncology

Introduction to Immunotherapy 

  • What is immunotherapy?
  • The role of the immune system in cancer treatment
  • Overview of different immunotherapy approaches (Monoclonal antibodies, checkpoint inhibitors, CAR-T)

CAR-T Therapy Basics

  • What is CAR-T (Chimeric Antigen Receptor T-cell) therapy?
  • Mechanism of CAR-T: How it works (T-cell modification and cancer cell targeting)
  • Historical development of CAR-T therapy
  • Overview of FDA-approved CAR-T therapies (e.g., Kymriah, Yescarta, Breyanzi)

The Science Behind CAR-T 

  • T-cell biology and role in immune response
  • CAR-T cell structure and function: Antigen recognition, CAR components
  • Process of CAR-T cell therapy (from patient cell collection to infusion)

Clinical Indications of CAR-T Therapy

  • Types of cancers treated with CAR-T (leukemia, lymphoma, etc.)
  • Patient selection and eligibility criteria
  • Success rates and key clinical outcomes

Q&A and Recap

  • Open floor for questions
  • Summary of key learnings from Day 1

Day 2: CAR-T Therapy Manufacturing and Clinical Applications

Recap of Day 1 and Key Takeaways

  • Brief review of the fundamentals of CAR-T therapy

CAR-T Manufacturing Process

  • Overview of the CAR-T cell production process
  • Steps: T-cell collection, genetic modification (viral vectors), CAR-T expansion, and infusion
  • Challenges in manufacturing (scalability, cost, and logistics)
  • Ensuring safety and efficacy during production
  • Automation and emerging trends in CAR-T manufacturing

Clinical Administration of CAR-T Therapy

  • Patient preparation: Lymphodepleting chemotherapy
  • The CAR-T infusion process
  • Managing side effects and toxicities: Cytokine Release Syndrome (CRS), Neurotoxicity
  • CAR-T monitoring and patient management post-infusion
  • Long-term follow-up and remission rates

Real-World Case Studies

  • Analysis of real-world CAR-T patient outcomes (success stories and challenges)
  • Discussion of clinical trials and their significance in CAR-T advancements
  • Case study presentations with interactive Q&A

Q&A and Recap 

  • Address any questions
  • Summarize the session learnings

Day 3: Future Directions, Challenges, and Ethical Considerations

Recap of Day 2 and Key Takeaways

  • Brief review of the CAR-T manufacturing and clinical process

Advancements and Innovations in CAR-T

  • Next-generation CAR-T therapies: Dual-targeting CARs, armored CARs, and universal CAR-T cells
  • CAR-NK and other cellular therapies in development
  • Use of CAR-T beyond hematologic malignancies (solid tumors)
  • Emerging technology: CRISPR and gene editing in CAR-T optimization

Overcoming Current Challenges

  • Resistance to CAR-T therapy and relapse in patients
  • Addressing high costs and accessibility issues
  • Managing side effects more effectively
  • Overcoming the complexity of treating solid tumors

Ethical and Regulatory Considerations

  • Ethical challenges in gene-modified therapies (access, cost, and equity)
  • Informed consent and patient education
  • Regulatory pathways for CAR-T approval (FDA, EMA)
  • Impact of CAR-T on the healthcare system (insurance coverage, cost of care)

Future of CAR-T: Looking Ahead

  • Predictions for the next 5–10 years in CAR-T therapy
  • Personalized medicine and the integration of AI and data in CAR-T treatment
  • Potential for CAR-T in combination therapies

Open Discussion and Q&A

  • Group discussion on the future of CAR-T
  • Audience questions and expert responses

Conclusion and Wrap-Up 

  • Recap of the entire 3-day workshop
  • Final thoughts and takeaways

Edit

Participant’s Eligibility

  • Undergraduate or graduate degree in Biotechnology, Immunology, Biomedical Sciences, or related fields.
  • Medical professionals, oncologists, and clinical researchers involved in cell-based therapies.
  • Individuals with an interest in gene therapy, cellular therapies, or advanced medical treatments.

Edit

Important Dates

Registration Ends

2024-12-18
Indian Standard Timing

Workshop Dates

2024-12-18 to 2024-12-20
Indian Standard Timing 3:00 PM

Workshop Outcomes

  • Master CAR-T cell biology and engineering principles.
  • Gain insights into the clinical applications of CAR-T therapies in cancer and other diseases.
  • Understand the regulatory and ethical frameworks governing CAR-T therapies.
  • Acquire practical skills in CAR-T cell manufacturing and quality control.
  • Explore future innovations and applications of CAR-T beyond oncology.

Edit

Mentor Profile

No Entries Found

Fee Structure

Student

INR. 1399
USD. 50

Ph.D. Scholar / Researcher

INR. 1699
USD. 55

Academician / Faculty

INR. 2199
USD. 60

Industry Professional

INR. 2699
USD. 85

We are excited to announce that we now accept payments in over 20 global currencies, in addition to USD. Check out our list to see if your preferred currency is supported. Enjoy the convenience and flexibility of paying in your local currency!
List of Currencies

FOR QUERIES, FEEDBACK OR ASSISTANCE

Contact Learner Support

Best of support with us

Phone (For Voice Call)


WhatsApp (For Call & Chat)

Key Takeaways

  • Access to Live Lectures
  • Access to Recorded Sessions
  • e-Certificate
  • Query Solving Post Workshop
wsCertificate

Future Career Prospects

  • Immunotherapy Research Scientist
  • Clinical Researcher in Oncology
  • CAR-T Cell Therapy Specialist
  • Regulatory Affairs Specialist in Biopharma
  • Cell and Gene Therapy Manufacturing Expert
  • Biotechnology Consultant

Edit

Country

Affiliation

Profession

Note: The information shown in the above-mentioned analytics is live and may include information that is not completely correct like spelling mistakes, grammatical mistakes , factual errors or even mis representation as this is what participants have entered, the information is currently not edited and or filtered , but at later stages they will be filtered to provide true data representation.

Enter the Hall of Fame!

Take your research to the next level!

Publication Opportunity
Potentially earn a place in our coveted Hall of Fame.

Centre of Excellence
Join the esteemed Centre of Excellence.

Networking and Learning
Network with industry leaders, access ongoing learning opportunities.

Hall of Fame
Get your groundbreaking work considered for publication in a prestigious Open Access Journal (worth ₹20,000/USD 1,000).

Achieve excellence and solidify your reputation among the elite!


×

Related Courses

Wastewater-Based Epidemiology: Pathogen Surveillance, Viral Monitoring & Public Health Analytics

Wastewater-Based Epidemiology: …

⭐️⭐️⭐️⭐️☆

Antibiotic Resistance Genomics: WGS, Bioinformatics & Resistance Gene Characterization

Antibiotic Resistance …

⭐️⭐️⭐️⭐️☆

Gut-Heart Axis: AI-Powered Metagenomics, Metabolomics & Cardiovascular Risk Prediction

Gut-Heart Axis: AI-Powered …

⭐️⭐️⭐️⭐️☆

Computational Nanomaterial Design for Drug Delivery: Molecular Modelling & Simulation

Computational Nanomaterial …

⭐️⭐️⭐️⭐️☆

Recent Feedbacks In Other Workshops

Antimicrobial Resistance Surveillance: Whole-Genome Sequencing, Resistome Analysis & Pathogen Tracking, AMR Genomic Surveillance: Whole-Genome Sequencing, Resistome Analysis & Genomic Epidemiology

exellent


Eman Rashwan : October 26, 2026 at 4:24 am

Photoelectrocatalysis for Green Hydrogen: Materials & Reactor Design

The mentor demonstrated knowledge of the topics. However, the lecture delivery could be improved More through clearer explanations, better pacing, and more practical examples to help participants follow the discussions.
Hanah Maurice D. Tabada : October 22, 2026 at 7:04 am

Photoelectrocatalysis for Green Hydrogen: Materials & Reactor Design

Excellent


Mahesh Kumar Dhakar : September 28, 2026 at 2:37 pm

View All Feedbacks
Biotechnology · Advanced · Video-based learning

Advanced Workshop on CAR-T Therapy- Oncology and Beyond

“Advancing CAR-T Therapy: From Oncology to Novel Applications”

Access 24/7 · 365 daysVideo lectures of 3+ hrsCertificate
Registration open

About This Course

CAR-T therapy has revolutionized the field of oncology, offering personalized and highly effective treatments for certain cancers. This 3-day workshop dives deep into the biological principles behind CAR-T therapy, from T-cell engineering to antigen targeting, along with real-world applications and case studies in oncology. Participants will explore the full therapeutic landscape, including FDA-approved therapies and emerging treatments.
Beyond oncology, CAR-T therapy is now being explored for autoimmune diseases, infectious diseases, and other non-cancerous conditions. The workshop will discuss the future directions of CAR-T research and clinical trials, addressing the current hurdles in scaling these therapies. Participants will also engage in sessions, including CAR-T cell manufacturing, regulatory frameworks, and understanding the ethical considerations surrounding gene editing and cellular therapies.

Aim

This advanced workshop on “CAR-T Therapy: Oncology and Beyond” aims to provide a comprehensive understanding of Chimeric Antigen Receptor (CAR) T-cell therapy, its mechanisms, clinical applications, and future potential beyond oncology. Participants will gain insights into the latest developments, challenges, and innovations in CAR-T therapy for both cancer treatment and other emerging applications.

Course Objectives

  • Understand the fundamentals of CAR-T cell biology and immunotherapy mechanisms.
  • Explore CAR-T therapy applications in oncology and beyond.
  • Learn about the latest innovations, clinical trials, and emerging applications.
  • Gain knowledge of CAR-T cell manufacturing and regulatory requirements.
  • Discuss ethical, safety, and scalability challenges in CAR-T therapy.
Next: Syllabus →

Syllabus

Module 1: Introduction to CAR-T Therapy

Workshop Overview 

  • Introduction to the workshop structure and objectives
  • Importance of CAR-T therapy in modern oncology

Introduction to Immunotherapy 

  • What is immunotherapy?
  • The role of the immune system in cancer treatment
  • Overview of different immunotherapy approaches (Monoclonal antibodies, checkpoint inhibitors, CAR-T)

CAR-T Therapy Basics

  • What is CAR-T (Chimeric Antigen Receptor T-cell) therapy?
  • Mechanism of CAR-T: How it works (T-cell modification and cancer cell targeting)
  • Historical development of CAR-T therapy
  • Overview of FDA-approved CAR-T therapies (e.g., Kymriah, Yescarta, Breyanzi)

The Science Behind CAR-T 

  • T-cell biology and role in immune response
  • CAR-T cell structure and function: Antigen recognition, CAR components
  • Process of CAR-T cell therapy (from patient cell collection to infusion)

Clinical Indications of CAR-T Therapy

  • Types of cancers treated with CAR-T (leukemia, lymphoma, etc.)
  • Patient selection and eligibility criteria
  • Success rates and key clinical outcomes

Q&A and Recap

  • Open floor for questions
  • Summary of key learnings from Day 1

Module 2: CAR-T Therapy Manufacturing and Clinical Applications

Recap of Day 1 and Key Takeaways

  • Brief review of the fundamentals of CAR-T therapy

CAR-T Manufacturing Process

  • Overview of the CAR-T cell production process
  • Steps: T-cell collection, genetic modification (viral vectors), CAR-T expansion, and infusion
  • Challenges in manufacturing (scalability, cost, and logistics)
  • Ensuring safety and efficacy during production
  • Automation and emerging trends in CAR-T manufacturing

Clinical Administration of CAR-T Therapy

  • Patient preparation: Lymphodepleting chemotherapy
  • The CAR-T infusion process
  • Managing side effects and toxicities: Cytokine Release Syndrome (CRS), Neurotoxicity
  • CAR-T monitoring and patient management post-infusion
  • Long-term follow-up and remission rates

Real-World Case Studies

  • Analysis of real-world CAR-T patient outcomes (success stories and challenges)
  • Discussion of clinical trials and their significance in CAR-T advancements
  • Case study presentations with interactive Q&A

Q&A and Recap 

  • Address any questions
  • Summarize the session learnings

Module 3: Future Directions, Challenges, and Ethical Considerations

Recap of Day 2 and Key Takeaways

  • Brief review of the CAR-T manufacturing and clinical process

Advancements and Innovations in CAR-T

  • Next-generation CAR-T therapies: Dual-targeting CARs, armored CARs, and universal CAR-T cells
  • CAR-NK and other cellular therapies in development
  • Use of CAR-T beyond hematologic malignancies (solid tumors)
  • Emerging technology: CRISPR and gene editing in CAR-T optimization

Overcoming Current Challenges

  • Resistance to CAR-T therapy and relapse in patients
  • Addressing high costs and accessibility issues
  • Managing side effects more effectively
  • Overcoming the complexity of treating solid tumors

Ethical and Regulatory Considerations

  • Ethical challenges in gene-modified therapies (access, cost, and equity)
  • Informed consent and patient education
  • Regulatory pathways for CAR-T approval (FDA, EMA)
  • Impact of CAR-T on the healthcare system (insurance coverage, cost of care)

Future of CAR-T: Looking Ahead

  • Predictions for the next 5–10 years in CAR-T therapy
  • Personalized medicine and the integration of AI and data in CAR-T treatment
  • Potential for CAR-T in combination therapies

Open Discussion and Q&A

  • Group discussion on the future of CAR-T
  • Audience questions and expert responses

Conclusion and Wrap-Up 

  • Recap of the entire 3-day workshop
  • Final thoughts and takeaways

Who Should Enrol?

  • Undergraduate or graduate degree in Biotechnology, Immunology, Biomedical Sciences, or related fields.
  • Medical professionals, oncologists, and clinical researchers involved in cell-based therapies.
  • Individuals with an interest in gene therapy, cellular therapies, or advanced medical treatments.

Course Outcomes

  • Master CAR-T cell biology and engineering principles.
  • Gain insights into the clinical applications of CAR-T therapies in cancer and other diseases.
  • Understand the regulatory and ethical frameworks governing CAR-T therapies.
  • Acquire skills in CAR-T cell manufacturing and quality control.
  • Explore future innovations and applications of CAR-T beyond oncology.
Next: Fees →

Course fee

Learners in India

₹2,499

Learners outside India

$50

  • Video lectures
  • Study material
  • Certificate after completion
  • 365-day access

Enrol in the course

Next: FAQ →

Frequently asked questions

How is this course taught?

Through recorded video lectures from the original live workshop, with the study material. Watch at your own pace, any time.

How long do I have access?

365 days from your registration, on your NanoSchool dashboard.

Do I get a certificate?

Yes, an e-certificate after completion, with a QR code anyone can verify and an "Add to LinkedIn" button.

How can I pay?

By card, UPI or PayPal on the payment page; international bank transfer is also available there.

What is the refund policy?

See our Returns, Refunds & Cancellation policy: Returns, Refunds & Cancellation policy

Need Help?

We’re here for you!


(+91) 120-4781-217
WhatsApp +91 99581 61117

Registration open

More upcoming workshops

Live, mentor-led and certified. Dates and times in IST.

See all workshops
Support